Ying L. Liu

Also affiliated with Cornell University, State Duma

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 44 papers. Top paper: “Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer”.

Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer

Nature Cancer(2022)10.1038/s43018-022-00388-9

N/A

0.879DataRank · unranked

350 citations

Emily A. Aherne, Lora H. Ellenson, Ines Nikolovski, Mohammed Alghamdi, Ignacio Vázquez-Garćıa +22 more

Ovarian cancer mutational processes drive site-specific immune evasion

Nature(2022)10.1038/s41586-022-05496-1

N/A

0.863DataRank · unranked

314 citations

Florian Uhlitz, Nicholas Ceglia, Jamie Lim, Michelle Wu, Neeman Mohibullah +56 more

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses

Nature Medicine(2024)10.1038/s41591-024-02942-7

N/A

0.790DataRank · unranked

26 citations

Beryl Manning‐Geist, Qin Zhou, Tara E. Soumerai, Aliya Holland, Arnaud Da Cruz Paula +23 more

Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer

npj Breast Cancer(2021)10.1038/s41523-021-00313-w

N/A

0.691DataRank · unranked

99 citations

Cecilie L. Bager, Nicholas Willumsen, Divya Ramchandani, Naomi Kornhauser, Ling Lu +12 more

Microsatellite Instability–High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0713

N/A

0.641DataRank · unranked

71 citations

Ying L. Liu, Kelly A. Devereaux, Arnaud Da Cruz Paula, Qin Zhou, Weining Ma +18 more

Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing

Annals of Oncology(2022)10.1016/j.annonc.2022.01.006

N/A

0.604DataRank · unranked

55 citations

Fresia Pareja, David N. Brown, Ozge Ceyhan‐Birsoy, Maksym Misyura, Satshil Rana +16 more

Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers with Therapeutic Implications

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0546

N/A

0.587DataRank · unranked

49 citations

Antonio Marra, Pier Selenica, Eric Rios‐Doria, Amir Momeni Boroujeni, Michael F. Berger +12 more

Disparities in cancer genetics care by race/ethnicity among pan‐cancer patients with pathogenic germline variants

Cancer(2022)10.1002/cncr.34434

N/A

0.571DataRank · unranked

44 citations

Anna Maio, Yelena Kemel, Erin Salo‐Mullen, Margaret Sheehan, Prince Ray Tejada +22 more

Ongoing genome doubling shapes evolvability and immunity in ovarian cancer

Nature(2025)10.1038/s41586-025-09240-3

N/A

0.553DataRank · unranked

39 citations

Ignacio Vázquez-Garćıa, Matthew Myers, Duaa H. Al-Rawi, Matthew Zatzman, Adam C. Weiner +53 more

Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade

Nature Medicine(2023)10.1038/s41591-023-02544-9

N/A

0.550DataRank · unranked

38 citations

Michael B. Foote, Benoı̂t Rousseau, Henry Walch, Yelena Kemel, Allison L. Richards +33 more

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

Cancer Epidemiology Biomarkers & Prevention(2022)10.1158/1055-9965.epi-21-1287

N/A

0.524DataRank · unranked

32 citations

Chaitanya Bandlamudi, Matthew D. Hellmann, Yelena Kemel, Esther Drill, Hira Rizvi +32 more

Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors

npj Genomic Medicine(2021)10.1038/s41525-021-00259-9

N/A

0.505DataRank · unranked

28 citations

Jung Hun Oh, Ying L. Liu, Pier Selenica, Britta Weigelt, Jorge S. Reis‐Filho +6 more

Comprehensive analysis of germline drivers in endometrial cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad016

N/A

0.470DataRank · unranked

22 citations

Eric Rios‐Doria, Karen A. Cadoo, Amanda Catchings, Anna Maio, Yelena Kemel +37 more

Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.008

N/A

0.457DataRank · unranked

20 citations

Mackenzie W. Sullivan, Qin Zhou, Alexia Iasonos, Pier Selenica, Chrystal Stallworth +9 more

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.11.019

N/A

0.449DataRank · unranked

19 citations

Pier Selenica, Thomas Boerner, Kara Long Roche, Yonghong Xiao, Tiffany Sia +23 more

Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.07.11.602772

N/A

0.415DataRank · unranked

11 citations

Ignacio Vázquez-Garćıa, Matthew Myers, Matthew Zatzman, Duaa H. Al-Rawi, Adam C. Weiner +52 more

Pathogenic germline variants in patients with endometrial cancer of diverse ancestry

Cancer(2023)10.1002/cncr.35071

N/A

0.406DataRank · unranked

14 citations

Sushmita Gordhandas, Kanika Arora, Eric Rios‐Doria, Karen A. Cadoo, Amanda Catchings +26 more

Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classification

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.09.008

N/A

0.406DataRank · unranked

14 citations

Andrea Gazzo, Satshil Rana, Pier Selenica, Nadeem R Abu-Rustum, Lora H. Ellenson +4 more

Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2023-005194

N/A

0.396DataRank · unranked

13 citations

Eric Rios‐Doria, Ying L. Liu, Lora H. Ellenson, Qin Zhou, Alexia Iasonos +5 more

Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer

Cancer(2024)10.1002/cncr.35523

N/A

0.330DataRank · unranked

8 citations

Stephen Graves, Anusha Adkoli, Qin Zhou, Alexia Iasonos, Lora H. Ellenson +8 more

Germline drivers of gynecologic carcinosarcomas

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.04.024

N/A

0.330DataRank · unranked

8 citations

Sushmita Gordhandas, Ozge Ceyhan‐Birsoy, Yelena Kemel, Anna Maio, Erin Salo‐Mullen +22 more

Moving into the modern era of molecular classification for endometrial cancer

Journal of Surgical Oncology(2023)10.1002/jso.27552

N/A

0.312DataRank · unranked

7 citations

Ying L. Liu, Jennifer J. Mueller, Britta Weigelt, Christian Dagher

Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.005

N/A

0.312DataRank · unranked

7 citations

Tiffany Sia, Christopher J. Fong, Aliya Khurram, Michele Waters, Yelena Kemel +19 more

Gene-specific outcomes in patients with Lynch syndrome treated by immune checkpoint blockade for advanced cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.10504

N/A

0.208DataRank · unranked

3 citations

Oliver Artz, Mohammad Ali Abbass, Emily Harrold, Michael B. Foote, Andrea Cercek +10 more

Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2023-004842

N/A

0.165DataRank · unranked

2 citations

Victoria Wan, Michael Finlan, Qin Zhou, Alexia Iasonos, Oliver Zivanovic +14 more

Geometric Network Analysis Provides Prognostic Information in Patients with High Grade Serous Carcinoma of the Ovary Treated with Immune Checkpoint Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.10.447889

N/A

0.165DataRank · unranked

2 citations

Jung Hun Oh, Ying L. Liu, Pier Selenica, Britta Weigelt, Jorge S. Reis‐Filho +6 more

Safety and feasibility of therapeutic anticoagulation for newly diagnosed venous thromboembolism in women who undergo neoadjuvant chemotherapy for advanced ovarian cancer

International Journal of Gynecological Cancer(2023)10.1136/ijgc-2023-004576

N/A

0.104DataRank · unranked

1 citations

Clarissa Lam, Derman Başaran, Ying L. Liu, Rachel N. Grisham, William P. Tew +9 more

Restoration of Spermatogenesis is Dependent on Activation of a SPRY4-ERK Checkpoint Following Germline Stem Cell Damage

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.12.681919

N/A

0DataRank · unranked

0 citations

Tansol Choi, Brad Pearson, Ryan Nachman, Whitney Woo, Na Xu +6 more

Early age of onset and broad cancer spectrum persist in MSH6 and PMS2-associated Lynch syndrome.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10516

N/A

0DataRank · unranked

0 citations

Karen A. Cadoo, Anna Maio, Zalak Patel, Yelena Kemel, Erin Salo‐Mullen +15 more

Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.059

N/A

0DataRank · unranked

89 citations

Amir Momeni Boroujeni, Claire F. Friedman, Pier Selenica, Qin Zhou, Michelle Wu +16 more

Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.022

N/A

0DataRank · unranked

11 citations

Beryl Manning‐Geist, Andrea Knežević, Luxue Deng, Maria Bromberg, Samuel A. Funt +13 more

Shedding Light on PARP Inhibitor Response through Functional Imaging

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3711

N/A

0DataRank · unranked

2 citations

Dmitriy Zamarin, Ying L. Liu

Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.07.006

N/A

0DataRank · unranked

3 citations

Beryl Manning‐Geist, Sarah Ehmann, Jessica A. Lavery, Carrie Luardo, Aaron Praiss +10 more

Data from Microsatellite Instability–High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles

(2023)10.1158/1078-0432.c.6532995.v1

N/A

0DataRank · unranked

0 citations

Ying L. Liu, Kelly A. Devereaux, Arnaud Da Cruz Paula, Qin Zhou, Weining Ma +18 more

Germline variants in non-BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5565

N/A

0DataRank · unranked

0 citations

Pier Selenica, Thomas Boerner, Yonghong Xiao, Tiffany Sia, Margaret Sheehan +15 more

Germline mutations in hereditary renal cell carcinoma (RCC) genes among 32,240 patients with all cancer types.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4559

N/A

0DataRank · unranked

0 citations

Andrew R. Schroeder, Semanti Mukherjee, Yelena Kemel, Ritesh R. Kotecha, Chung‐Han Lee +12 more

Pathogenic germline variants in patients with endometrial cancer across diverse ancestries.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5596

N/A

0DataRank · unranked

0 citations

Sushmita Gordhandas, Kanika Arora, Anna Maio, Yelena Kemel, Margaret Sheehan +15 more

A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair‐deficient and microsatellite instability‐high endometrial cancers

Cancer(2024)10.1002/cncr.35267

N/A

0DataRank · unranked

20 citations

Britta Weigelt, Ying L. Liu

Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005522

N/A

0DataRank · unranked

9 citations

Nadeem R. Abu‐Rustum, Kaled M. Alektiar, Vicky Makker, Ying L. Liu, Dmitriy Zamarin +8 more

Association between genomic instability score and progression-free/overall survival in patients with newly diagnosed non-BRCA1/2 ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.11.011

N/A

0DataRank · unranked

3 citations

Mackenzie W. Sullivan, Anusha Adkoli, Qin Zhou, Alexia Iasonos, Pier Selenica +10 more

Gestational trophoblastic neoplasm: Patient outcomes and clinical pearls from a multidisciplinary referral center

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.12.009

N/A

0DataRank · unranked

2 citations

Aaron Praiss, Sarah Chiang, Kelly A. Devereaux, James Huang, Gabrielle Rizzuto +6 more

Germline landscape of ovarian cancer across age groups: Spotlight on elderly patients.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.10583

N/A

0DataRank · unranked

0 citations

Sara Moufarrij, Qin Zhou, Aliya Khurram, Yelena Kemel, Alexia Iasonos +6 more

Pathogenic germline variants among women with uterine cancer by ancestry: A commercial laboratory collaborative research registry study

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.585

N/A

0DataRank · unranked

3 citations

Chinmayi Aryasomayajula, Alex Francoeur, Chelsea Stewart, Tiffany Sia, Kathleen M. Darcy +5 more

Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.08.016

N/A

0DataRank · unranked

1 citations

Sara Moufarrij, Juliet Milani, Sarah Kane, Qin Zhou, Christopher J. Fong +20 more